Join the Hypothyroidism group to help and get support from people like you.
Hypothyroidism News
Related terms: Low Thyroid
FDA Upgrades Recall on 160,000+ Bottles of Thyroid Medication
THURSDAY, July 24, 2025 — The U.S. Food and Drug Administration (FDA) has upgraded a recall of a commonly prescribed thyroid medication due to what it described as "subpotent" active ingredients. The ...
Age-, Sex-, Race-Specific Standards for Thyroid Diseases May Reclassify Many Patients
WEDNESDAY, May 14, 2025 – Age-, sex-, and race-specific reference intervals for thyroid diseases reclassify many participants with subclinical hypothyroidism or hyperthyroidism as normal, according...
Could the Common Thyroid Medicine Levothyroxine Weaken Bones?
MONDAY, Nov. 25, 2024 – New research suggests that a thyroid medication often prescribed to older Americans may be linked to a common problem in old age – bone loss. Levothyroxine is a synthetic...
RSNA: Levothyroxine Tied to Bone Loss Over Time in Older Adults
MONDAY, Nov. 25, 2024 – Levothyroxine (LT4) use is associated with longitudinal loss of bone mass and density in older adults, according to a study scheduled to be presented at the annual meeting of...
Potential Genetic Link ID'd Between Thyroid Disease, Alopecia Areata
WEDNESDAY, Oct. 30, 2024 – There seems to be a significant association between hypothyroidism, Hashimoto thyroiditis, subacute thyroiditis, and alopecia areata (AA), according to a study published...
Study Looks at Impact of Hypothyroidism, Hypothyroxinemia in Pregnancy
WEDNESDAY, Aug. 21, 2024 – For women with subclinical hypothyroidism (SH) or hypothyroxinemia (HT) diagnosed during the first half of pregnancy, SH is associated with higher rates of overt...
FDA Medwatch Alert: IBSA Pharma Inc. Issues Voluntary Nationwide Recall of Select Lots of Tirosint®-Sol (levothyroxine sodium) Oral Solution Due to Subpotency
February 01, 2023 – IBSA Pharma Inc. is voluntarily recalling 27 lots of TIROSINT®-SOL (levothyroxine sodium) Oral Solution to the consumer level. This voluntary recall has been initiated ...
FDA Medwatch Alert: Acella Pharmaceuticals, LLC, Issues Voluntary Nationwide Recall of Certain Lots of NP Thyroid® (Thyroid Tablets, USP) Due to Sub Potency
April 30, 2021 – Acella Pharmaceuticals, LLC, is voluntarily recalling certain lots listed in the Tables 1 and 2 below of 15-mg, 30-mg, 60-mg, 90-mg and 120-mg NP Thyroid®, Thyroid Tablets, USP ...
FDA Medwatch Alert: Westminster Pharmaceuticals, LLC. Issues Voluntary Nationwide Recall of Levothyroxine and Liothyronine (Thyroid Tablets, USP) Due to Risk of Adulteration
Announcement: Westminster Pharmaceuticals, LLC is voluntarily recalling all lots, within expiry, of Levothyroxine and Liothyronine (Thyroid Tablets, USP) 15 mg, 30 mg, 60 mg, 90 mg, & 120 mg to the...
Further information
Related condition support groups
Hypothyroidism - After Thyroid Removal, Thyroid Disease